Chemoprevention of aflatoxin B1-induced carcinogenesis by indole-3-carbinol in rat liver - predicting the outcome using early biomarkers

Carcinogenesis

Volumn 19, Issue 10, 1998, Pages 1829-1836

  Manson, Margaret M ^a   Ann Hudson, E ^a   Ball, Helen W L ^a   Barrett, Mandy C ^a   Clark, Helen L ^a   Judah, David J ^a   Verschoyle, Richard D ^a   Neal, Gordon E ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

3 INDOLEMETHANOL; AFLATOXIN B1; ALDEHYDE REDUCTASE; CYTOCHROME P450 ISOENZYME; CYTOKERATIN; GAMMA GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; ORNITHINE DECARBOXYLASE; PROTEIN TYROSINE KINASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); AFLATOXIN B1 ALDEHYDE REDUCTASE; ANTINEOPLASTIC AGENT; CARCINOGEN; CYTOCHROME P450; INDOLE DERIVATIVE; INDOLE-3-CARBINOL; KERATIN; TUMOR MARKER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CHEMICAL CARCINOGENESIS; CHEMOPROPHYLAXIS; CONTROLLED STUDY; ENZYME INDUCTION; LIVER CARCINOGENESIS; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PREDICTION; PRIORITY JOURNAL; RAT; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG ANTAGONISM; FISCHER 344 RAT; LIVER TUMOR; METABOLISM; PRECANCER;

AFLATOXIN B1; ALDEHYDE REDUCTASE; ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOGENS; CYTOCHROME P-450 ENZYME SYSTEM; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE TRANSFERASE; INDOLES; KERATINS; LIVER NEOPLASMS, EXPERIMENTAL; MALE; PRECANCEROUS CONDITIONS; RATS; RATS, INBRED F344; TUMOR MARKERS, BIOLOGICAL;

EID: 0031595917     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/19.10.1829     Document Type: Article

References (47)

1. Bailey,G.S., Hendricks,J.D., Shelton,D.W., Nixon,J.E. and Pawlowski,N. (1987) Enhancement of carcinogenesis by the natural anti carcinogen indole-3-carbinol. J. Natl Cancer Inst., 78, 931-934.
2. 1 carcinogenesis by the natural tumor modulator indole-3-carbinol: influence of dose duration and intermittent exposure on indole-3-carbinol promotional potency. Cancer Res., 51, 2362-2365.
3. Kim,D.J., Lee,K.K., Han,B.S., Ahn,B., Bae,J.H. and Jang,J.J. (1994) Biphasic modifying effect of indole-3-carbinol on diethylnitrosamine-induced preneoplastic glutathione-S-transferase placental form-positive liver-cell foci in Sprague-Dawley rats. Jpn. J. Cancer Res., 85, 578-583.
4. Tanaka,T., Kojima,T., Morishita,Y. and Mori,H. (1992) Inhibitory effects of the natural products indole-3-carbinol and sinigrin during initiation and promotion phases of 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Jpn. J. Cancer Res., 83, 835-842.
5. Grubbs,C.J., Steele,V.E., Casebolt,T., Juliana,M.M., Eto,I, Whitaker,L.M., Dragnev,K.H., Kelloff,G.J. and Lubet,R.L. (1995) Chemoprevention of chemically-induced mammary carcinogenesis by indole-3-carbinol. Anticancer Res., 15, 709-716.
6. 1 in rainbow trout. Carcinogenesis, 7, 2025-2031.
7. 1. Carcinogenesis, 9, 427-432.
8. 1 carcinogen dose, indole-3-carbinol anti-carcinogen dose, target organ DNA adduction and final tumour response. Carcinogenesis, 10, 175-181.
9. 1 in the rat. Drug Metab. Dispos., 22, 383-391.
10. 1 metabolism. Carcinogenesis, 18, 1729-1738.
11. 1 exo-epoxide-association with reduced levels of hepatic aflatoxin DNA adducts in vivo. Drug Metab. Dispos., 22, 392-399.
12. 1. Pharmacol. Ther., 50, 443-472.
13. 1 is expressed in rat liver during carcinogenesis and following the administration of an antioxidant. Biochem. J., 292, 13-18.
14. 1. Carcinogenesis, 8, 723-728.
15. 1 hepatocarcinogenesis in the rat. Cancer Res., 47, 5218-5223.
16. Tatematsu,M., Nagamine,Y. and Farber,E. (1983) Redifferentiation as a basis for remodelling of carcinogen-induced hepatocyte nodules to normal appearing liver. Cancer Res., 43, 5049-5058.
17. Stamatoglou,S.C, Manson,M.M., Green,J.A., Mayol,X. and Hughes,R.C. (1991) Distribution of fibronectin and fibronectin-binding proteins, Agp 110 and integrin α5β1 during chemically induced hepatocarcinogenesis in adult rats. J. Cell Sci., 100, 599-604.
18. Green,J.A., Stamatoglou,S.C., Gordon,L.A. and Manson,M.M., (1993) Use of multiple markers to identify a subset of preneoplastic foci in liver most likely to progress to tumour. Hum. Exp. Toxicol., 12, 576.
19. Omura,T and Sato,R. (1964) The carbon monoxide binding pigment of liver microsomes. J. Biol. Chem., 239, 2370-2378.
20. Habig,W.H., Pabst,M.J. and Jakoby,W.B. (1974) Glutathione S-transferases. The first enzymic step in mercapturic acid formation. J. Biol. Chem., 249, 7130-7139.
21. Prochaska,H.J. and Santamaria,A.B. (1988) Direct measurement of NAD(P)H:quinone reductase from cells cultured in microtitre wells: a screening assay for anticarcinogenic enzyme inducers. Anal. Biochem., 169, 328-336.
22. 1-8,9-epoxide. Biochem. J., 279, 385-398.
23. Tanaka,T., Kojima,T., Kawamori,T., Yoshimi,N. and Mori,H. (1993) Chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis by a simple phenolic acid protocatechuic acid in rats. Cancer Res., 53, 2775-2779.
24. Lichti,U. and Gottesman,M.M. (1982) Genetic evidence that a phorbol ester tumor promoter stimulates ornithine decarboxylase activity by a pathway that is independent of cyclic AMP-dependent protein kinases in CHO cells. J. Cell Physiol., 113, 433-439.
25. Sharma,S., Stutzman,J.D., Kelloff,G.J. and Steele,V.E. (1994) Screening of potential chemopreventive agents using biochemical markers of carcinogenesis. Cancer Res., 54, 5848-5855.
26. Green,J.A. and Manson,M.M. (1992) Production of polyclonal antisera. In Manson,M.M. (ed.) Methods in Molecular Biology, Vol. 10, Immunochemical Protocols. Humana Press, Totowa, NJ, pp. 1-5.
27. Hayes,J.D., Judah,D.J. and Neal,G.E. (1993) Resistance to aflatoxin B, is associated with the expression of a novel aldo-keto reductase which has catalytic activity toward a cytotoxic aldehyde-containing metabolite of the toxin. Cancer Res., 53, 3887-3894.
28. 1-induced carcinogenesis. Int. J. Cancer, 34, 869-874.
29. 1-induced carcinogenesis. Carcinogenesis, 11, 1175-1182.
30. 1 and susceptibilities to γ-glutamyl p-phenylene diamine mustard of γ-glutamyl transferase negative and positive cell lines. Carcinogenesis, 2, 661-67.
31. Bauman,P.A., Dalton,W.S., Anderson,J.M. and Cress,A.E. (1994) Expression of cytokeratin confers multiple drug resistance. Proc. Natl Acad. Sci. USA, 91, 5311-5314.
32. Anderson,J.M., Heindl,L.M., Bauman,P.A., Ludi,C.W., Dalton,W.S. and Cress,A.E. (1996) Cytokeratin expression results in a drug-resistant phenotype to six different chemotherapeutic agents. Clin. Cancer Res., 2, 97-105.
33. Cadrin,M., McFarlane Anderson,N., Aasheim,L.H., Kawahara,H., Franks,D.J., Marceau,N. and French,S.W. (1992) Differential phosphorylation of CK8 and CK18 by 12-O-tetradecanoyl-phorbol-13-acetate in primary cultures of mouse hepatocytes. Cell. Signalling, 4, 715-722.
34. Anilkumar,T.V., Golding,M., Edwards,R.J., Lalani,E.N., Sarraf,C.E. and Alison,M.R. (1995). The resistant hepatocyte model of carcinogenesis in the rat: the apparent independent development of oval cell proliferation and early nodules. Carcinogenesis, 16, 845-853.
35. Ohta,T., Nishiwaki T., Yatsunami,J., Komori,A., Suganuma,M. and Fujiki,H. (1992) Hyperphosphorylation of cytokeratins 8 and 18 by microcystin-LR, a new liver tumour promoter, in primary cultured rat hepatocytes. Carcinogenesis, 13, 2443-2447.
36. Matsushima Nishiwaki,R.M., Shidoji,Y., Nishiwaki,S., Yamada,T., Moriwaki,H. and Muto,Y. (1995) Suppression by carotenoids of microcystin-induced morphological changes in mouse hepatocytes. Lipids, 30, 1029-1034.
37. Fukuda,K., Kojiro,M. and Chui,J.F. (1993) Cross-linked cytokeratin polypeptides in liver and hepatoma cells: possible association with the process of cell degeneration and death. Hepatology, 17, 118-124.
38. BenZeev,A., Robinson,G.S., Bucher,N.L.R. and Farmer,S.R. (1993) Cell-cell and cell-matrix interactions differentially regulate the expression of hepatic and cytoskeletal genes in primary culture of rat hepatocytes. Proc. Natl Acad. Sci. USA, 85, 2161-2165.
39. Schwartz,J.L., West,K., Shklar,D.P. and Shklar,G. (1995) Altered cytokeratin expression in carcinogenesis - inhibition by antitumour nutrients. Nutr. Cancer, 24, 47-56.
40. Smets,G., Van Ginckel,R., Daneels,G., Moeremans,M., Van Wauwe,J., Coene,M.C, Ramaekers,F.C.S., Schalken,J.A., Borgers,M. and De Coster,R. (1995) Liarozole, an antitumor drug, modulates cytokeratin expression in the Dunning AT-6sq prostatic carcinoma through in situ accumulation of all-trans-retinoic acid. Prostate, 27, 129-140.
41. Malkinson,A.M. and Thaete,L.G. (1986) Effects of strain and age on prophylaxis and co-carcinogenesis of urethane-induced mouse lung adenomas by butylated hydroxytoluene. Cancer Res., 46, 1694-1697.
42. Manson,M.M., Green,J.A., Wright,B.J. and Carthew,P. (1992) Degree of ethoxyquin induced nephrotoxicity in rat is dependent on age and sex. Arch. Toxicol., 66, 51-56.
43. 1 on rat liver nuclei. Cancer Res., 36, 1771-1778.
44. 1 or an azo dye. Br. J. Cancer, 37, 55-60.
45. Bradlow,H.L., Michnovicz,JJ., Halper,M., Miller,D.G., Wong,G.Y.C. and Osborne,M.P. (1994) Long-term responses of women to indole-3-carbinol or a high-fiber diet. Cancer Epidemiol. Biomarkers Prevent., 3, 591-595.
46. Kojima,T., Tanaka,T. and Mori,H. (1994) Chemoprevention of spontaneous endometrial cancer in female Donryu rats by dietary indole-3-carbinol. Cancer Res., 54, 1446-1449.
47. Cover,C.M., Hsieh,S.J., Tran,S.H., Hallden,G., Kim,G.S., Bjeldanes,L.F. and Firestone,G.L. (1998) Indole-3-earbinol inhibits the expression of cyclin-dependent kinase-6 and induces a G1 cell cycle arrest of human breast cancer cells independent of estrogen receptor signalling. J. Biol. Chem., 273, 3838-3847.